RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 13 analysts with an average price target of $298.02. This is a potential upside of $17.85 (6.37%) from yesterday's end of day stock price of $280.17.

ResMed's activity chart (see below) currently has 96 price targets and 125 ratings on display. The stock rating distribution of RMD is 64.91% BUY, 33.33% HOLD and 1.75% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 68.46% with an average time for these price targets to be met of 171.94 days.

Highest price target for RMD is $290, Lowest price target is $248, average price target is $249.43.

Most recent stock forecast was given by ANTHONY PETRONE from MIZUHO on 16-Jul-2025.

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Currently out of the existing stock ratings of RMD, 37 are a BUY (64.91%), 19 are a HOLD (33.33%), 1 are a SELL (1.75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$270

$-1.94 (-0.71%)

$250

23 days ago
(16-Jul-2025)

12/12 (100%)

$15.75 (6.19%)

106

Hold

$248

$-23.94 (-8.80%)

$260

3 months 15 days ago
(24-Apr-2025)

3/3 (100%)

$11.9 (5.04%)

70

Buy

$285

$13.06 (4.80%)

$250

3 months 15 days ago
(24-Apr-2025)

5/6 (83.33%)

$48.9 (20.71%)

30

Buy

$290

$18.06 (6.64%)

$286

3 months 15 days ago
(24-Apr-2025)

16/18 (88.89%)

$53.9 (22.83%)

380

Hold

6 months 8 days ago
(31-Jan-2025)

11/11 (100%)

$-7.67 (-3.15%)

212

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RMD (ResMed) average time for price targets to be met?

On average it took 171.94 days on average for the stock forecasts to be realized with a an average price target met ratio 68.46

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

MATTHEW MISHAN

Which analyst has the most public recommendations on RMD (ResMed)?

Matthew Mishan works at KEYBANK and has 3 price targets and 7 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Mike Polark with highest potential upside - $50.08

Which analyst is the currently most reserved on RMD (ResMed)?

Joanne Wuensch with lowest potential downside - -$151.94

ResMed in the News

This ResMed Insider Reduced Their Stake By 72%

From what we can see, insiders were net sellers in ResMed Inc.’s (NYSE:RMD ) during the past 12 months. That is, insiders sold the stock in greater numbers than they purchased it. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider...

Resmed acquires independent diagnostic testing facility VirtuOx

Health technology company Resmed has acquired the software-enabled independent diagnostic testing facility VirtuOx, aiming to bolster its position in supporting patients earlier in their healthcare journey and simplifying care delivery for providers and homecare companies. VirtuOx offers services for respiratory, cardiac and sleep conditions. Its virtual testing platform is designed to minimise diagnostic barriers by...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?